LIND vs VRTX · rev $407.3M vs P/E 30, rev $3.33B
Lindblad Expeditions Holdings Inc (LIND) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Lindblad Expeditions Holdings Inc (LIND) is a travel services company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported LIND revenue for 2026-06-30 was $407.3M. Net income was $5.1M. Revenue was up 95.8% from 2026-03-31 to 2026-06-30. LIND currently screens at market cap $699.7M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
LIND currently screens at market cap $699.7M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the LIND and VRTX stock pages for the full models.
Not investment advice.